WHO recommends Phase III trial of Ebola vaccine against Bundibugyo virus
The World Health Organisation (WHO) has recommended a Phase III trial of an Ebola vaccine to test whether it can protect against Bundibugyo virus disease.
Unlike Ebola virus disease caused by the Ebola virus, there is currently no licensed vaccine specifically approved for the prevention of Bundibugyo virus disease.
Laboratory testing confirmed Bundibugyo virus disease, prompting the DRC government to declare its 17th Ebola outbreak.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
